Proton Pump Inhibitors Linked to Chronic Kidney Disease
Proton Pump Inhibitors (PPIs), such as Prevacid®, Prilosec® and Nexium®, are commonly prescribed to treat heartburn and acid reflux disease. These popular medications are the leading sellers among pharmaceutical drugs and research shows that they have been found to increase the risk of developing kidney disease and kidney failure.
A recent 2016 study published in the Journal of the American Medical Association (JAMA) found that the longer patients take Proton Pump Inhibitors, the more likely they are to develop chronic kidney disease. The study analyzed the medical records of 10,482 patients, excluding those with preexisting kidney conditions. Researchers found that the use of PPIs increased patients’ risk for developing chronic kidney disease by up to 50%.
Schlichter Bogard & Denton is currently investigating claims against the manufacturers of Proton Pump Inhibitors, which likely knew about the risks associated with Prevacid, Prilosec and Nexium but failed to warn medical professionals and patients about them.
If you or someone you know has suffered kidney disease or other kidney injuries while taking a Proton Pump Inhibitor, such as Prevacid, Prilosec or Nexium, you may be entitled to compensation.